macrophage metalloelastase inhibitors (Novartis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemacrophage metalloelastase inhibitors (Novartis)
Drug Alias NameMME inhibitors (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 12 inhibitors
TargetsMatrix metalloproteinase 12
Therapy Area/IndicationsEmphysema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsEmphysema

Other Information

ATC CodeN/A
Related LinksN/A